Report Detail

Other Global Actinic Keratosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3664718
  • |
  • 27 August, 2019
  • |
  • Global
  • |
  • 122 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Global Actinic Keratosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

    1 Actinic Keratosis Treatment Market Overview

    • 1.1 Product Overview and Scope of Actinic Keratosis Treatment
    • 1.2 Classification of Actinic Keratosis Treatment by Types
      • 1.2.1 Global Actinic Keratosis Treatment Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Actinic Keratosis Treatment Revenue Market Share by Types in 2018
      • 1.2.3 Destructive Treatment
      • 1.2.4 Photodynamic Therapy
      • 1.2.5 Topical Medications
      • 1.2.6 Other
    • 1.3 Global Actinic Keratosis Treatment Market by Application
      • 1.3.1 Global Actinic Keratosis Treatment Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital
      • 1.3.3 Clinic
      • 1.3.4 Other
    • 1.4 Global Actinic Keratosis Treatment Market by Regions
      • 1.4.1 Global Actinic Keratosis Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Actinic Keratosis Treatment Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Actinic Keratosis Treatment Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Actinic Keratosis Treatment Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Actinic Keratosis Treatment Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Actinic Keratosis Treatment Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Actinic Keratosis Treatment (2014-2024)

    2 Manufacturers Profiles

    • 2.1 DUSA Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 Actinic Keratosis Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 DUSA Pharmaceuticals Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Novartis
      • 2.2.1 Business Overview
      • 2.2.2 Actinic Keratosis Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Novartis Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Perrigo
      • 2.3.1 Business Overview
      • 2.3.2 Actinic Keratosis Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Perrigo Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 LEO Pharma
      • 2.4.1 Business Overview
      • 2.4.2 Actinic Keratosis Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 LEO Pharma Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Bausch Health
      • 2.5.1 Business Overview
      • 2.5.2 Actinic Keratosis Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Bausch Health Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Taro Pharmaceutical
      • 2.6.1 Business Overview
      • 2.6.2 Actinic Keratosis Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Taro Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Galderma (Nestle)
      • 2.7.1 Business Overview
      • 2.7.2 Actinic Keratosis Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Galderma (Nestle) Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Biofrontera
      • 2.8.1 Business Overview
      • 2.8.2 Actinic Keratosis Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Biofrontera Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Almirall
      • 2.9.1 Business Overview
      • 2.9.2 Actinic Keratosis Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Almirall Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Tolmar Pharmaceutical
      • 2.10.1 Business Overview
      • 2.10.2 Actinic Keratosis Treatment Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Tolmar Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Actinic Keratosis Treatment Market Competition, by Players

    • 3.1 Global Actinic Keratosis Treatment Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Actinic Keratosis Treatment Players Market Share
      • 3.2.2 Top 10 Actinic Keratosis Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Actinic Keratosis Treatment Market Size by Regions

    • 4.1 Global Actinic Keratosis Treatment Revenue and Market Share by Regions
    • 4.2 North America Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 4.5 South America Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)

    5 North America Actinic Keratosis Treatment Revenue by Countries

    • 5.1 North America Actinic Keratosis Treatment Revenue by Countries (2014-2019)
    • 5.2 USA Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Actinic Keratosis Treatment Revenue by Countries

    • 6.1 Europe Actinic Keratosis Treatment Revenue by Countries (2014-2019)
    • 6.2 Germany Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 6.3 UK Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 6.4 France Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Actinic Keratosis Treatment Revenue by Countries

    • 7.1 Asia-Pacific Actinic Keratosis Treatment Revenue by Countries (2014-2019)
    • 7.2 China Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 7.5 India Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)

    8 South America Actinic Keratosis Treatment Revenue by Countries

    • 8.1 South America Actinic Keratosis Treatment Revenue by Countries (2014-2019)
    • 8.2 Brazil Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Actinic Keratosis Treatment by Countries

    • 9.1 Middle East and Africa Actinic Keratosis Treatment Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)

    10 Global Actinic Keratosis Treatment Market Segment by Type

    • 10.1 Global Actinic Keratosis Treatment Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Actinic Keratosis Treatment Market Forecast by Type (2019-2024)
    • 10.3 Destructive Treatment Revenue Growth Rate (2014-2024)
    • 10.4 Photodynamic Therapy Revenue Growth Rate (2014-2024)
    • 10.5 Topical Medications Revenue Growth Rate (2014-2024)
    • 10.6 Other Revenue Growth Rate (2014-2024)

    11 Global Actinic Keratosis Treatment Market Segment by Application

    • 11.1 Global Actinic Keratosis Treatment Revenue Market Share by Application (2014-2019)
    • 11.2 Actinic Keratosis Treatment Market Forecast by Application (2019-2024)
    • 11.3 Hospital Revenue Growth (2014-2019)
    • 11.4 Clinic Revenue Growth (2014-2019)
    • 11.5 Other Revenue Growth (2014-2019)

    12 Global Actinic Keratosis Treatment Market Size Forecast (2019-2024)

    • 12.1 Global Actinic Keratosis Treatment Market Size Forecast (2019-2024)
    • 12.2 Global Actinic Keratosis Treatment Market Forecast by Regions (2019-2024)
    • 12.3 North America Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
    • 12.4 Europe Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
    • 12.6 South America Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.

      Scope of the Report:
      The classification of Actinic Keratosis Treatment includes Destructive Treatment, Photodynamic Therapy, Topical Medications and Other, and the Most of Actinic Keratosis Treatment is Destructive Treatment, and proportion of Destructive Treatment in 2017 is about 81.4%. Cryotherapy was the most ordinarily looked for treatment by clinicians. Notwithstanding, better clinical consequences of photodynamic treatment and developing inclination for medications in view of medication gadget mix have asked both parental figures and patients to choose novel treatment techniques that offer both propelled adequacy, stylish advantages and decreased danger of future malignancies.
      Actinic Keratosis Treatment is widely used in hospital, clinic and other. The most proportion of Actinic Keratosis Treatment is used in clinic, and the proportion in 2017 is about 63%.
      Market competition is intense. DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. The major company of Photodynamic Therapy for Actinic Keratosis Treatment is DUSA Pharmaceuticals, Galderma (Nestle), Biofrontera in USA.
      The global Actinic Keratosis Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Actinic Keratosis Treatment.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Actinic Keratosis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Actinic Keratosis Treatment market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      DUSA Pharmaceuticals
      Novartis
      Perrigo
      LEO Pharma
      Bausch Health
      Taro Pharmaceutical
      Galderma (Nestle)
      Biofrontera
      Almirall
      Tolmar Pharmaceutical

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Destructive Treatment
      Photodynamic Therapy
      Topical Medications
      Other

      Market Segment by Applications, can be divided into
      Hospital
      Clinic
      Other


      Summary:
      Get latest Market Research Reports on Actinic Keratosis Treatment. Industry analysis & Market Report on Actinic Keratosis Treatment is a syndicated market report, published as Global Actinic Keratosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Actinic Keratosis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,785.02
      4,177.53
      5,570.04
      3,154.05
      4,731.07
      6,308.10
      375,432.84
      563,149.26
      750,865.68
      247,371.62
      371,057.44
      494,743.25
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report